인공 췌장 기기 시스템(APDS) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Artificial Pancreas Device Systems (APDS) Market size is expected to reach USD 2.19 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 9.19% during 2026-2034.

The Global Artificial Pancreas Device Systems (APDS) Market is witnessing robust growth due to the rising prevalence of diabetes worldwide. Increasing awareness about advanced diabetes management solutions and the need for continuous glucose monitoring are driving adoption. Technological advancements integrating insulin pumps, continuous glucose monitors, and control algorithms have improved treatment accuracy. Growing healthcare expenditure and favorable reimbursement policies in developed regions are further supporting market expansion.

Key growth drivers include the rising geriatric population and increasing cases of Type 1 and Type 2 diabetes. Continuous innovations in closed-loop systems that automate insulin delivery are enhancing patient convenience and glycemic control. Collaboration between medical device manufacturers and digital health companies is accelerating product development. Additionally, growing patient preference for minimally invasive and wearable solutions is strengthening demand across hospitals and homecare settings.

In the future, the market is expected to benefit from artificial intelligence integration and improved sensor accuracy. Expanding healthcare infrastructure in emerging economies will create new growth opportunities. Companies are focusing on cost reduction and product miniaturization to improve accessibility. As personalized medicine and remote monitoring gain traction, the Global Artificial Pancreas Device Systems (APDS) Market is projected to experience sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Threshold Suspend Device Systems
• Control-To-Range (CTR) Systems
• Control-To-Target (CTT) Systems

By End User

• Hospitals
• Clinics
• Homecare

COMPANIES PROFILED

• Medtronic plc, Bigfoot Biomedical Inc, Pancreum Inc, Johnson Johnson, Beta Bionics Inc, TypeZero Technologies LLC, Insulet Corporation, Diabeloop, Tandem Diabetes Care Inc, Inreda Diabetic
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Threshold Suspend Device Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Control-To-Range (CTR) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Control-To-Target (CTT) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Device Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Device Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Device Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Device Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Device Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic Plc
  • 8.2.2 Bigfoot Biomedical Inc
  • 8.2.3 Pancreum Inc
  • 8.2.4 Johnson & Johnson
  • 8.2.5 Beta Bionics Inc
  • 8.2.6 TypeZero Technologies LLC
  • 8.2.7 Insulet Corporation
  • 8.2.8 Diabeloop
  • 8.2.9 Tandem Diabetes Care Inc
  • 8.2.10 Inreda Diabetic